Safety and Tolerability of CVHNLC Plus Pembrolizumab in Patients With Squamous Non Small-Cell Lung Cancer (sqNSCLC)
Clinical trial NCT07073183 · WITHDRAWN
Trial details
- NCT number
- NCT07073183
- Sponsor
- CureVac
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-30
- Primary completion
- 2029-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.